Biofil Chemicals and Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Biofil Chemicals and Pharmaceuticals has a total shareholder equity of ₹182.0M and total debt of ₹4.4M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are ₹470.8M and ₹288.8M respectively. Biofil Chemicals and Pharmaceuticals's EBIT is ₹8.1M making its interest coverage ratio 19.6. It has cash and short-term investments of ₹22.8M.
Key information
2.4%
Debt to equity ratio
₹4.39m
Debt
| Interest coverage ratio | 19.6x |
| Cash | ₹22.84m |
| Equity | ₹182.03m |
| Total liabilities | ₹288.80m |
| Total assets | ₹470.83m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524396's short term assets (₹384.1M) exceed its short term liabilities (₹285.2M).
Long Term Liabilities: 524396's short term assets (₹384.1M) exceed its long term liabilities (₹3.6M).
Debt to Equity History and Analysis
Debt Level: 524396 has more cash than its total debt.
Reducing Debt: 524396's debt to equity ratio has reduced from 12% to 2.4% over the past 5 years.
Debt Coverage: 524396's debt is well covered by operating cash flow (545.4%).
Interest Coverage: 524396's interest payments on its debt are well covered by EBIT (19.6x coverage).